Abstract
Neurotechnology holds immense promise for revolutionizing the treatment of neurological disorders which are globally the most economically burdensome indications. This talk follows the entrepreneurial journey of translating research into successful neurotechnology startups, focusing on two case studies: a venture-funded deep brain stimulation (DBS) therapy for Parkinson's Disease, and an innovative Stereoencephalogram (SEEG) solution for epilepsy - both with roots at EPFL in Switzerland. We will cover a toolkit for Academic and/or Physician medical device entrepreneurs with best practices for successfully translating their potential therapies and setting them up for venture capital or strategic partnerships.
